Type 1 Diabetes Insulin Requirements
For adults with type 1 diabetes, start with a total daily insulin dose of 0.5 units/kg/day, divided approximately 50% as basal insulin and 50% as prandial insulin across meals, using multiple daily injections or continuous subcutaneous insulin infusion. 1
Initial Dosing Algorithm
Standard Starting Dose
- Total daily insulin requirement: 0.4-1.0 units/kg/day 1
- Typical starting dose for metabolically stable patients: 0.5 units/kg/day 1
- Distribution: 40-50% as basal insulin, 50-60% as prandial insulin 1, 2
Special Populations Requiring Dose Adjustments
- Honeymoon phase or residual beta-cell function: 0.2-0.6 units/kg/day 1, 2
- Diabetic ketoacidosis presentation: Higher weight-based doses required 1
- Puberty: Significantly higher doses often needed, potentially exceeding 1.0 units/kg/day 1
- Pregnancy and acute illness: Increased requirements 1
Insulin Delivery Methods
Multiple Daily Injections (MDI)
- 3-4 injections per day combining basal and prandial insulin 1
- Long-acting basal analog (glargine, degludec, or detemir) once or twice daily 1
- Rapid-acting analog (lispro, aspart, or glulisine) before each meal 1
Continuous Subcutaneous Insulin Infusion (CSII)
- Approximately 50% of total daily dose as basal infusion, 50% as meal-related boluses 3
- Modest advantages over MDI: 0.30 percentage point lower A1C, reduced severe hypoglycemia 1
- Automated insulin delivery (AID) systems preferred when feasible for improved time in range and reduced hypoglycemia 1
Insulin Type Selection
Basal Insulin
Use long-acting analogs (glargine U-100/U-300, degludec, or detemir) rather than NPH insulin to reduce hypoglycemia risk, particularly nocturnal episodes. 1
Prandial Insulin
Use rapid-acting analogs (lispro, aspart, or glulisine) rather than regular human insulin to reduce hypoglycemia risk and improve postprandial control. 1
- Administer 0-15 minutes before meals 3, 4
- Faster-acting insulin aspart offers enhanced postprandial coverage 1, 5
Prandial Insulin Dosing Strategy
Carbohydrate Counting Education
Patients must be educated to match prandial insulin doses to carbohydrate intake, premeal blood glucose, and anticipated physical activity. 1
- Advanced education on fat and protein impact for those who master carbohydrate counting 1
Timing Considerations
- Rapid-acting analogs: 0-15 minutes before meals 3, 4
- Timing should be individualized based on premeal glucose level 1
Monitoring Requirements
Blood Glucose Monitoring
Daily self-monitoring of blood glucose is essential for all patients receiving insulin therapy. 1, 2
- Continuous glucose monitoring (CGM) should be considered standard of care for most patients with type 1 diabetes 1
- Sensor-augmented pump therapy with threshold-suspend feature reduces nocturnal hypoglycemia without increasing A1C 1
Dose Adjustment Frequency
Reassess insulin doses every 3-6 months or more frequently during active titration. 1
Critical Pitfalls to Avoid
Inadequate Basal Coverage
Do not use basal insulin doses below 40% of total daily insulin in stable patients, as this leads to inadequate between-meal and overnight glucose control. 1, 2
Excessive Basal Insulin
When basal insulin exceeds 0.5-1.0 units/kg/day without achieving glycemic targets, add or optimize prandial insulin rather than continuing to escalate basal insulin alone. 1, 2
- Signs of overbasalization: bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, high glucose variability 1, 2
Delayed Insulin Administration
Administering rapid-acting insulin after meals rather than before significantly impairs postprandial glucose control. 2
Injection Site Neglect
Rotate injection sites within the same region (abdomen, thigh, upper arm, or buttocks) to prevent lipodystrophy, which distorts insulin absorption. 3, 4
Hypoglycemia Management Failure
Immediately reduce insulin dose by 10-20% after any episode of severe hypoglycemia. 1, 2
Glycemic Targets
Standard Targets for Most Adults
- A1C: <7% (53 mmol/mol) 5
- Fasting/preprandial glucose: 80-130 mg/dL (4.4-7.2 mmol/L) 1, 2
- Postprandial glucose (1-2 hours after meals): <180 mg/dL (10.0 mmol/L) 1
Pediatric Targets
For all children with type 1 diabetes, including preschool children: A1C <7.5% (58 mmol/mol) to minimize hyperglycemia, severe hypoglycemia, and long-term complications. 4